Development of a two-site solid-phase immunochemiluminescent assay for measurement of dimeric inhibin-A in human serum and other biological fluids

10Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.

Abstract

Inhibin is a heterodimeric glycoprotein that inhibits the secretion of follitropin from the pituitary and has been isolated in two distinct forms composed of a common α subunit and either a β(A) or β(B) subunit. Utilizing paired monoclonal antibodies specific to the α and β(A) subunit, we have developed an immunochemiluminescent assay for dimeric inhibin-A. The assay is capable of quantifying free and bound inhibin-A in human serum and follicular fluid. The limit of detection is 10 ng/L. Related proteins exhibit little cross-reactivity or interference. Recovery is excellent. Whereas samples from men and postmenopausal women are near the detection limit of the assay, inhibin-A is higher in the luteal than the follicular phase of normally cycling women, 20-fold higher during in vitro fertilization treatment, and ~200-fold greater in pregnancy. The assay measures inhibin-A in follicular fluid from a variety of other species.

Cite

CITATION STYLE

APA

McConnell, D. S., Padmanabhan, V., Pollak, T. B., Groome, N. P., Ireland, J. J., & Midgley, J. (1996). Development of a two-site solid-phase immunochemiluminescent assay for measurement of dimeric inhibin-A in human serum and other biological fluids. Clinical Chemistry, 42(8), 1159–1167. https://doi.org/10.1093/clinchem/42.8.1159

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free